BNP Paribas Asset Management
CRMD icon

BNP Paribas Asset Management’s CorMedix CRMD Stock Holding History

BNP Paribas Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Sell
1,334
-225
-14% -$1.78K ﹤0.01% 2219
2026
Q1 		$10.6K Buy
1,559
+525
+51% +$3.88K ﹤0.01% 2205
2025
Q4 		$12K Buy
1,034
+265
+34% +$2.93K ﹤0.01% 2092
2025
Q3 		$9K Buy
769
+169
+28% +$2.04K ﹤0.01% 1660
2025
Q2 		$7K Buy
+600
New +$6.62K ﹤0.01% 1883

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BNP Paribas Asset Management's CRMD Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its CorMedix (CRMD) stake by 14% in Q2 2026, selling an estimated $1.78K and leaving 1,334 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2219.

BNP Paribas Asset Management first reported a position in CRMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $12K in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • BNP Paribas Asset Management held 1,334 shares of CorMedix worth $10.5K as of Q2 2026.
  • BNP Paribas Asset Management sold 225 CorMedix shares in Q2 2026, an estimated $1.78K.
  • CorMedix made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2219 holding.
  • BNP Paribas Asset Management first reported a position in CorMedix in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's CorMedix position peaked at $12K in Q4 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.